[ad_1]
Aurora Cannabis, Inc. (NASDAQ: ACB ) on Friday reported a narrower net loss for the second quarter of 2023. The company’s revenue rose 2% year-over-year during the quarter.
The Canadian-based medical marijuana company reported a net loss from continuing operations of C$67.2 million for the second quarter, compared with a loss of C$75.1 million in the year-ago period. Adjusted EBITDA was C$1.4 million for the three months, compared to a loss of C$7.1 million in the prior-year quarter. Total revenue increased by 2% year-on-year to C$61.7 million.
Read management/analyst commentary on monthly reports
“We have the right size business while remaining Canada’s #1 LP in global medical cannabis revenue, and have shown organic quarterly revenue growth across all cannabis segments through Q2 2023,” said Miguel Martin, executive director. from Aurora Cannabis.
Previous Performance
[ad_2]
Source link